Evidence map›Paper›PMID 33510212›Full record

ArticleScientific reports2021

Redirecting substrate regioselectivity using engineered ΔN

Mounir Benkoulouche, Akli Ben Imeddourene, Louis-Antoine Barel, Guillaume Le Heiget, Sandra Pizzut, Hanna Kulyk, Floriant Bellvert, Sophie Bozonnet, Laurence A Mulard, Magali Remaud-Siméon and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Mounir Benkoulouche *Toulouse Biotechnology Institute, TBI, Université de Toulouse, CNRS, INRAE, INSA, 135, avenue de Rangueil, 31077, Toulouse Cedex 04, France.
Akli Ben Imeddourene *Toulouse Biotechnology Institute, TBI, Université de Toulouse, CNRS, INRAE, INSA, 135, avenue de Rangueil, 31077, Toulouse Cedex 04, France.
Louis-Antoine BarelUnité de Chimie des Biomolécules, Institut Pasteur, UMR3523 CNRS, 28, rue du Dr Roux, 75724, Paris Cedex 15, France.
Guillaume Le HeigetUnité de Chimie des Biomolécules, Institut Pasteur, UMR3523 CNRS, 28, rue du Dr Roux, 75724, Paris Cedex 15, France.
Sandra PizzutToulouse Biotechnology Institute, TBI, Université de Toulouse, CNRS, INRAE, INSA, 135, avenue de Rangueil, 31077, Toulouse Cedex 04, France.
Hanna KulykToulouse Biotechnology Institute, TBI, Université de Toulouse, CNRS, INRAE, INSA, 135, avenue de Rangueil, 31077, Toulouse Cedex 04, France.
Floriant BellvertToulouse Biotechnology Institute, TBI, Université de Toulouse, CNRS, INRAE, INSA, 135, avenue de Rangueil, 31077, Toulouse Cedex 04, France.
Sophie BozonnetToulouse Biotechnology Institute, TBI, Université de Toulouse, CNRS, INRAE, INSA, 135, avenue de Rangueil, 31077, Toulouse Cedex 04, France.
Laurence A MulardUnité de Chimie des Biomolécules, Institut Pasteur, UMR3523 CNRS, 28, rue du Dr Roux, 75724, Paris Cedex 15, France.
Magali Remaud-SiméonToulouse Biotechnology Institute, TBI, Université de Toulouse, CNRS, INRAE, INSA, 135, avenue de Rangueil, 31077, Toulouse Cedex 04, France.
Claire MoulisToulouse Biotechnology Institute, TBI, Université de Toulouse, CNRS, INRAE, INSA, 135, avenue de Rangueil, 31077, Toulouse Cedex 04, France. claire.moulis@insa-toulouse.fr.
Isabelle AndréToulouse Biotechnology Institute, TBI, Université de Toulouse, CNRS, INRAE, INSA, 135, avenue de Rangueil, 31077, Toulouse Cedex 04, France. isabelle.andre@insa-toulouse.fr.
Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement · FRInstitut National des Sciences Appliquées de Toulouse · FRCentre National de la Recherche Scientifique · FRInstitut Pasteur · FRSorbonne Paris Cité · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The (chemo-)enzymatic synthesis of oligosaccharides has been hampered by the lack of appropriate enzymatic tools with requisite regio- and stereo-specificities. Engineering of carbohydrate-active enzymes, in particular targeting the enzyme active site, has notably led to catalysts with altered regioselectivity of the glycosylation reaction thereby enabling to extend the repertoire of enzymes for carbohydrate synthesis. Using a collection of 22 mutants of ΔN

Indexed as

Bacterial ProteinsProtein EngineeringSucraseHaptensOligosaccharidesShigella flexneriBacterial ProteinsHaptensOligosaccharidesSucrase

Identifiers

PMID33510212
PMCPMC7844235
OpenAlexW3123212839

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.